# Epstein-Barr Virus (EBV)-Associated Myopericarditis Provoking Severe Heart Failure in an Immunocompetent Young Male

## TL;DR

A young, healthy man developed severe heart failure due to Epstein-Barr virus-induced myopericarditis, a rare condition in immunocompetent individuals.

## Contribution

This case report highlights the rare occurrence of EBV-associated myopericarditis in an immunocompetent young adult.

## Key findings

- A 28-year-old immunocompetent male developed severe heart failure from EBV-induced myopericarditis.
- The patient was treated with NSAIDs, colchicine, and heart failure medications, with planned close follow-up.
- This case underscores the importance of considering viral etiologies in young patients with unexplained heart failure.

## Abstract

Myopericarditis, a rare inflammatory condition affecting the heart and its surrounding layers, can lead to serious consequences if not promptly diagnosed and treated. A recent case involved a 28-year-old man with no significant medical history who developed severe chest pain and was diagnosed with myopericarditis induced by the Epstein-Barr virus (EBV). The patient's symptoms, imaging, and lab test results suggest myopericarditis. Initially, he was treated with non-steroidal anti-inflammatory drugs (NSAIDs) and colchicine, and upon discharge, he continued with NSAIDs, as well as guideline-directed medical therapy, including an angiotensin-converting enzyme inhibitor, beta blocker, and SGLT2 inhibitor. Close follow-up with the cardiology and heart failure programs was planned. This case highlights the rare occurrence of this condition in individuals with a healthy immune system.